|
Support list criteria utilizing a weighted point system has been
adopted based on RCA scores, risk control workshop attendance,
participation in claims reviews, board meeting attendance and funding
based loss ratios for the two most recently completed policy years.
Following are the criteria. A total of 1000 points is possible.
Risk Control Assessment Score (RCA)
(300 points possible)
Examples: A company with a Risk Control Assessment score of 87% receives
261 points. (87 X 3)
Risk Control Workshop Attendance
(100 points possible – 50 per for the most recent two workshops)
Participation in Claims Reviews
(150 points possible – 75 per for the most recent two claims reviews)
If a company does not qualify for a claim review (no losses > $10k) points are awarded.
Board Meeting Attendance
(50 points possible – 25 per for the most recent two meetings)
Funding Based Loss Ratio (Most recent complete policy period)
(100 to 250 pts. Sliding scale if less than 55% - negative numbers accrued if over 55%)
Funding Based Loss Ratio (Next most recent complete policy period)
(50 to 150 pts. Sliding scale if less than 75% - negative numbers accrued if over 75%)
Computation for June meeting based on loss runs as of March 31st, and
computation for January meeting based on loss runs as of October 31st.
The 55% and 75% were selected based on losses at those levels likely
developing into 100% loss ratios by the time those years are closed.
Risk Sharing
Any company causing risk sharing in 2 of the 3 most recent complete
policy years is automatically place on the support list.
Support List Process
- All member companies are scored and the 5% lowest scoring members
are automatically placed on the support list.
- Any causing risk sharing as per the above will be added to the Support List.
- Any member not meeting the minimum RCA score by their third full policy year
in the program will be added to the Support List.
- Any member remaining on the support list for 6
consecutive meetings will be referred to the underwriting
committee for further review.
|